Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

Completed

Plain-English translation of NCT03855137 on ClinicalTrials.gov ↗ · Source last updated February 2023 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(150 sites)

United States

Barrow Neuro Institute /ID# 236776, Phoenix, Arizona

Baptist Health Center for Clinical Research /ID# 237361, Little Rock, Arkansas

California Headache and Balance Center /ID# 236246, Fresno, California

Wr-Pri Llc /Id# 236008, Los Alamitos, California

Pharmacology Research Institute (PRI) - Newport Beach (Wake) /ID# 237692, Newport Beach, California